Skip to main content

Table 4 Multivariable Regression Models of Patient-Reported Receipt of Colorectal Cancer Surveillance

From: A dyadic survey study of partner engagement in and patient receipt of guideline-recommended colorectal cancer surveillance

 

Receipt of cross-sectional imaging

Receipt of endoscopy

Receipt of CEA

Receipt of all surveillance components

 

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

Partner Characteristics

Informed

0.96 (0.50–1.85)

1.12 (0.76–1.65)

1.10 (0.85–1.43)

0.95 (0.73–1.24)

Extent of involvement

1.23 (0.62–2.46)

0.60 (0.34–1.03)

0.75 (0.55–1.04)

0.67 (0.48–0.93)

Satisfaction with Involvement

0.92 (0.45–1.88)

1.07 (0.66–1.72)

1.17 (0.87–1.57)

1.28 (0.95–1.73)

Aware

1.46 (0.65–3.27)

2.18 (1.15–4.12)

0.83 (0.54–1.28)

1.30 (0.91–2.04)

Annual Household Income

    

<$40,000

REF

REF

REF

REF

$40,000-$89,999

2.88 (0.62–13.30)

4.16 (1.19–14.59)

1.97 (0.92–4.21)

2.47 (1.07–5.70)

≥$90,000

1.47 (0.31–7.04)

1.36 (0.41–4.57)

2.08 (0.94–4.59)

2.03 (0.86–4.77)

Patient Characteristics

Receipt of chemotherapy

    

No

REF

REF

REF

REF

Yes

4.84 (0.74–31.66)

9.97 (1.78–55.70)

0.91 (0.23–3.64)

8.85 (0.98–80.08)